Chronic myeloid leukemia (CML) is characterized by the oncogenic BCR-ABL1 fusion gene expression, which codes for a leukemogenic tyrosine kinase [1]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.